ArticleAnnals of hematology2025

Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.